Wed10242018

Robins Global News & Noticias



  • Odds: Packers vs. Bears
    Odds: Packers vs. Bears
  • Featured Guest Post
    Featured Guest Post
  • Featured Guest Post
    Featured Guest Post
  • Trump Pence News
    Trump Pence News
  • Weather Alerts
    Weather Alerts

Special News Reports

+ Larger Font | + Smaller Font

Consumer Daily Reports

Consumer News: FDA shames companies accused of blocking generic drug development

PhotoOn Thursday, the Food and Drug Administration (FDA) publicly called out companies charged with blocking the development of generic drugs. According to generic manufacturers, brand name manufacturers are responsible for countless hurdles that delay production and development of generic medication, and this list is designed to put an end to that.

“Today we’re making a public list of companies that have potentially been blocking access to the samples of their branded products,” said FDA Commissioner Scott Gottlieb. “We hope that this increased transparency will help reduce unnecessary hurdles to generic drug development and approval.”

To ensure that generic medications are safe for consumer use -- and identical to the brand name -- generic drug makers need brand name manufacturers to be on their team, as they need access to the brand name samples. The now-public list shows each complaint generic drug companies have made against the brand name companies.

Companies like Pfizer, GlaxoSmithKline, Novartis, and Valeant Pharmaceuticals -- just to name a few -- made the list of brand name companies that have been thwarting generic drug production. Additionally, Celegne topped the list with 13 complaints made against it to the FDA.

“No patients should be priced out of medicines they need to support their health,” Gottlieb said.

What this means for consumers

This move by the FDA comes after the White House released its plan to reduce drug prices for consumers. The plan, released last Friday, has four major goals: increasing competition, easing negotiation, creating incentives for lower prices, and lowering out-of-pocket spending on drugs.

The way the current system stands, drug companies have free reign to charge whatever they see fit for their products. With a new drug comes the ability to patent it; however, the FDA can also grant exclusivity to prevent competition in the market for certain periods of time. While drugmakers have various ways of doing this, their main tactic is to try to prevent competitors from creating copies.

“At times, certain ‘gaming tactics’ have been used to delay generic competition,” the FDA said in a statement. “One example of such gaming is when potential generic applicants are prevented from obtaining samples of certain brand products necessary to support approval of a generic drug. The inability of generic drug companies to purchase the samples they need slows down, or entirely impedes, the generic drug development process -- leading to delays in bringing affordable generic alternatives to patients in need.”

“This is a great day for for patients, since the administration’s list makes the definitive case why brand-name drug companies must stop blocking generic competition,” said Allen Goldberg, vice president of communications for the Association of Accessible Medicines.

There is currently legislation in the works that will aid in limiting what brand-name manufacturers can do to block generic competition. The CREATES Act has bipartisan support and will make it easier for generic manufacturers to sue for their right to provide consumers with cheaper copies of brand-name drugs. Despite support from both sides of the aisle, the bill is being held up amidst great opposition from drug companies.

“All the scheming and exploitation of our government’s rules means more profits for corporations at the expense of everyday Americans struggling to get the life-saving medicines they need,” said Tahir Amin, co-founder of Initiative for Medicines, Access & Knowledge.



Posted: 2018-05-18 11:44:34

Get Full News Story On Consumer Affairs


Listen to this article. Speaker link opens in a new window.
Text To Speech BETA Test Version.






Print Friendly and PDF Share Embed


Related News Stories From The Web And More

Related Bing News

Consumer News: FDA shames companies accused of blocking generic drug development | Consumer Daily Reports - Newscast

FDA names drugmakers accused of blocking cheaper generics

Mon, 21 May 2018 05:59:00 GMT

U.S. drug regulators are ... to ensure the safety of generic versions on the market since its three drugs on the list carries serious risks including birth defects. Celgene is accused of using a secon...

Naming Names: FDA Calls Out Drugmakers For Blocking Generics To Shame Them Into Better Behavior

Fri, 18 May 2018 05:56:00 GMT

The Associated Press: FDA Names Drugmakers Accused Of Blocking Cheaper Generics U.S. drug regulators ... increased transparency will help reduce unnecessary hurdles to generic drug development and app...

FDA names drugmakers accused of blocking cheaper generics

Thu, 17 May 2018 12:32:00 GMT

The Food and Drug Administration's new webpage names the makers of more than 50 brand-name drugs, some carrying six-figure annual price tags, who are under scrutiny. The agency also lists how many inq...

FDA names drugmakers accused of blocking cheaper generics

Thu, 17 May 2018 11:56:00 GMT

TRENTON, N.J. — U.S. drug regulators ... ensure the safety of generic versions on the market since its three drugs on the list carries serious risks including birth defects. Celgene is accused of usin...

FDA names drugmakers accused of blocking cheaper generics

Thu, 17 May 2018 11:33:00 GMT

TRENTON, N.J. (AP) — U.S. drug regulators ... ensure the safety of generic versions on the market since its three drugs on the list carries serious risks including birth defects. Celgene is accused of ...

Related Bing Web Search

Wednesday, November 1, 2017 | Kaiser Health News

(Tue, 09 Oct 2018 13:35:00 GMT)

Note To Readers. Planning for end-of-life medical care can be daunting and uncomfortable, which is why so many people put it off – or don’t do it at all.

Escitalopram - Wikipedia

(Fri, 12 Oct 2018 07:41:00 GMT)

Escitalopram, sold under the brand names Cipralex and Lexapro among others, is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class. Escitalopram is mainly used to treat major depressive disorder or generalized anxiety disorder. It is taken by mouth. Common side effects include trouble sleeping, nausea, sexual problems, and feeling tired.

Hair Loss: Propecia can cause permanent erectile dysfunction

(Fri, 05 Oct 2018 22:16:00 GMT)

It’s officially documented: Propecia can cause prolonged sexual side effects as well permanent erectile dysfunction. Propecia is a controversial drug manufactured by Merck which contains finasteride, a synthetic antiandrogen that inhibits type II 5-alpha reductase, the enzyme that converts testosterone to dihydrotestosterone (DHT). Finasteride was initially approved by the FDA in 1992 under ...

Antipsychotic - Wikipedia

(Tue, 09 Oct 2018 15:16:00 GMT)

Antipsychotic drug treatment is a key component of schizophrenia treatment algorithms recommended by the National Institute of Health and Care Excellence (NICE), the American Psychiatric Association, and the British Society for Psychopharmacology. The main effect of treatment with antipsychotics is to reduce the so-called "positive" symptoms, including delusions and hallucinations.

Springfield Business News | Jobs, Development, Economy

(Tue, 09 Oct 2018 22:47:00 GMT)

The growth in new apartment construction in the Dayton market is helping keep down rent costs for renters. Average rent for a two bedroom apartment in Dayton was $848 last month, down from $852 in ...

DPIC | Death Penalty Information Center

(Sun, 07 Oct 2018 23:53:00 GMT)

The Tennessee Supreme Court heard oral argument on October 3, 2018 of an appeal brought by 32 death-row prisoners challenging the constitutionality of the state's execution protocol. In a move criticized by one of the court's justices as a “rocket docket,” the court removed the case from a lower court and set argument for one week before Tennessee's scheduled October 11 execution of Edmund ...

Part II. Core Issues for All Schools to Consider

(Thu, 11 Oct 2018 13:54:00 GMT)

The restrictions on student speech lasted into the 20th century. In 1908, for example, the Wisconsin Supreme Court ruled that school officials could suspend two students for writing a poem ridiculing their teachers that was published in a local newspaper. 1 The Wisconsin court reasoned, “such power is essential to the preservation of order, decency, decorum, and good government in the public ...

Crime Scene Training: Latent Fingerprints

(Fri, 12 Oct 2018 04:21:00 GMT)

Crime Scene Training A blog to teach the fundamentals of Crime Scene Investigation, and to encourage input, feedback and involvement from site visitors.

Fetch.News

(Thu, 11 Oct 2018 10:48:00 GMT)

The world of independent media, all in one place.

Home | Turnitin

(Fri, 12 Oct 2018 05:47:00 GMT)

Turnitin provides instructors with the tools to prevent plagiarism, engage students in the writing process, and provide personalized feedback.

Related News Story Videos From Youtube

Trump vows to lower prescription drug costs


Related Videos On: Trump vows to lower prescription drug costs


Obama Blocks Poor Nations' Access to Affordable Drugs


Related Videos On: Obama Blocks Poor Nations' Access to Affordable Drugs


NAFTA to USMCA | Special coverage of the U.S.-Mexico-Canada Agreement


Related Videos On: NAFTA to USMCA | Special coverage of the U.S.-Mexico-Canada Agreement


State of the Union Address 2018 and Democratic response: Coverage and live stream from CBSN


Related Videos On: State of the Union Address 2018 and Democratic response: Coverage and live stream from CBSN


The National for Monday December 18, 2017 - Train derailment, Trump, Sherman deaths


Related Videos On: The National for Monday December 18, 2017 - Train derailment, Trump, Sherman deaths






Blow Us A Whistle

Comments (Whistles) Designed By Disqus




Company Information

Official Content Providers











PRIVACY POLICY

We recommend Firefox 3 (and above), Edge, and Chrome for dynamic performance.
© 2008-2018 RobinsPost (The Bird's Eye View Company) All rights are reserved.
RobinsPost provides links to news sites based on their RSS feeds.
All trademarks, copyrights, videos, photos and logos are owned by news sources.
News stories, videos and live streams are from trusted sources.
ROBINSPOST Is Proudly Made In America.
Where Quality, Safety and Service Comes First.